scPharmaceuticals Inc

NASDAQ:SCPH   3:59:53 PM EDT
5.46
-0.02 (-0.36%)
Products, Other Pre-Announcement

ScPharmaceuticals Inc Announces Receipt Of Written Minutes From Type C Meeting With FDA Regarding Development Of Furoscix

Published: 07/01/2021 12:17 GMT
scPharmaceuticals Inc (SCPH) - Scpharmaceuticals Inc. Announces Receipt of Written Minutes From Type C Meeting With the FDA Regarding Development of Furoscix®.
Scpharmaceuticals Inc - Furoscix NDA Resubmission Targeted for Q4 2021.
Scpharmaceuticals Inc - FDA and Company in Alignment on Path Forward.
Scpharmaceuticals Inc - FDA Has Not Requested Modifications to Device.
Scpharmaceuticals - Ended Q1 of 2021 With Cash, Equivalents, Restricted Cash & Investments of $96.5 Million.
Scpharmaceuticals - Believes Cash, Equivalents, Restricted Cash & Investments Sufficient to Fund Operations Into 2023.